Fundraising FoxUtility Therapeutics
acquired by Alembic Pharmaceuticals2 known investors
Find your way into Utility Therapeutics
Sign up to see every warm intro you have to Utility Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Utility Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Obtained U.S. FDA approval for pivmecillinam for the treatment of urinary tract infections; acquired by Alembic Pharmaceuticals in July 2025.
Investors · 2
Frequently asked questions
- What does Utility Therapeutics do?
- Obtained U.S. FDA approval for pivmecillinam for the treatment of urinary tract infections; acquired by Alembic Pharmaceuticals in July 2025.
- Who are Utility Therapeutics's investors?
- Utility Therapeutics's investors include 3B Future Health Fund, AMR Action Fund.
- Who acquired Utility Therapeutics?
- Utility Therapeutics was acquired by Alembic Pharmaceuticals.